drugset / Trial / NCT05326139

Topical Tranexamic Acid Application in Rhinoplasty

NCT05326139

Phase 4 Completed 50 enrolled Baskent University
RandomizedParallel-groupTriple-blindPrevention

Summary

The aim of this study is to examine the effectiveness of topical Tranexamic acid application in overcoming periorbital ecchymosis and edema after rhinoplasty, which are common and do not have a standard treatment.

Timeline

Start
2021-06-07
Primary completion
2021-09-17
Completion
2021-10-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 250 mg Topical

Indications